Skip to search formSkip to main contentSkip to account menu

somatostatin analogue therapy

Known as: Somatostatin Analog Therapy, therapy, somatostatin analogue 
Endocrine drug therapy that uses analogs of somatostatin to treat neuroendocrine tumors.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
A 10-year-old girl developed L-asparaginase (ASP)-associated pancreatitis during chemotherapy for acute lymphocytic leukemia. Her… 
2015
2015
We read with great attention the paper recently published in Endocrine by Campana et al. about type I gastric neuroendocrine… 
Review
2011
Review
2011
4078 Background: Systemic treatment options for advanced NET continue to be limited. In the phase III RADIANT-2 study, everolimus… 
Review
2010
Review
2010
Renal cell carcinoma (RCC) and neuroendocrine tumors (NET) are uncommon malignancies, highly resistant to chemotherapy, that have… 
2009
2009
Background. A 48-year-old man presented with diarrhea, flushing, abdominal pain and weight loss of 10 kg over a 6-month period… 
Review
2009
Review
2009
According to epidemiological studies, the prevalence of pituitary adenomas is 16.5% and the majority of them are "incidentalomas… 
2008
2008
We report the use of Gamma knife radiosurgery (GK) to 15 somatotroph adenomas. Eight patients had refractory acromegaly despite… 
2002
2002
Carcinoid tumors of the lung are rare neuroendocrine tumors that make up approximately 1 to 2% of all lung neoplasms. These… 
1987
1987
An 8-week-old infant presented with vomiting and failure to thrive due to small bowel obstruction caused by a diffusely enlarged…